Infliximab for Injection
Efficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
The first infliximab biosimilar marketed in China
Infliximab for Injection (Reminton), a recombinant anti-TNF-alpha chimeric monoclonal antibody, was approved for marketing by the National Medical Products Administration (NMPA) on July 14, 2021. It is the first infliximab biosimilar marketed in China. Taking advantage of CHO cell expression system, Remin_x005f ton has been proved with good efficacy, better safety, and lower immunogenicity in clinical studies.
Indications:
Crohn's disease in adults and children over 6 years of age, stulizing Crohn's disease,
ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, and psoriasis.
Recommended reading
Related products
-
Quick View
The Benefits of Roof Insulation: Is it a Wise Investment?
Read moreRoof insulation is a topic that often goes unnoticed, yet it plays a crucial role in maintaining a comfortable and energy-efficient home. Many homeowners wonder whether insulating their roof is a good idea. In this article, we will delve into the benefits of roof insulation, exploring its impact on energy efficiency, cost savings, and overall …
The Benefits of Roof Insulation: Is it a Wise Investment?Read More
-
Quick View
Fusce ullamcorper dapibus
Original price was: $55.00.$41.00Current price is: $41.00.Add to cartVestibulum quis augue sem. Curabitur non vehicula elit, et cursus tortor. Quisque placerat velit nec nulla sodales, porttitor mattis tortor porta. Praesent gravida leo nibh, vel semper nulla lobortis vel. Donec nisl velit, iaculis ac dolor eget, blandit elementum urna. Mauris pellentesque posuere pellentesque. Nunc fermentum purus a consequat fringilla. Donec finibus suscipit erat in pharetra
-
Quick View
Phasellus varius turpis
$56.00Add to cartPhasellus varius turpis consequat enim tincidunt, id aliquam orci hendrerit. Curabitur quis accumsan nisl, in condimentum magna. Fusce nec diam et dolor ornare rhoncus nec ut mauris. In eleifend mi in felis dictum fermentum. Morbi vel arcu sit amet dolor venenatis bibendum in eu dui.
-
Quick View
Phasellus molestie id mi sit amet
$66.00Add to cartMorbi mattis ipsum sem, in gravida dolor venenatis vestibulum. Aenean laoreet, nisi in bibendum dictum, purus libero accumsan enim, id vehicula enim metus vitae ipsum. Maecenas nulla est, dictum quis augue ultrices, dictum rutrum enim. Aliquam erat volutpat.
Reviews
There are no reviews yet.